Barclays Maintains an 'Overweight' Rating on AmerisourceBergen (ABC); Analyst Day Prep - 10K Review Highlights Medco Health Growth
Tweet Send to a Friend
Barclays maintains an 'Overweight' rating on AmerisourceBergen (NYSE: ABC), PT $39.
Barclays analyst says, "In preparation for the AmerisourceBergen analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "In preparation for the AmerisourceBergen analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
